Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

NCT01211275 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Netherlands Cancer Institute

Collaborators